AmarencoPLabreucheJLavalleePTouboulPJ: Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke2004; 35:2902–9.
2.
BallantyneCM: Current and future aims of lipid-lowering therapy: changing paradigms and lessons from the heart protection study on standards of efficacy and safety. Am J Cardiol2003; 92(Suppl.): 3K–9K.
3.
The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators.High-dose atorvastatin after stroke or transient ischemic attack. New Engl J Med2006; 355:549–59.
4.
Heart Protection Study Collaborative Group: MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebo-controlled trial. Lancet2002; 360:7–22.
5.
EndresMLaufsUHuangZ. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA1998; 95:8880–5.
6.
Amin-HanjaniSStaglianoNEYamadaMHuangPLLiaoJKMoskowitzMA: Mevastatin, an HMG-coa reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke2001; 32:980–6.
7.
LaufsUGertzKDirnaglUBöhmMNickenigGEndresM: Rosuvastatin, a new HMG-coa reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Brain Res2002; 942:23–30.
8.
GertzKLaufsULindauerU. Withdrawal of statin treatment abrogates stroke protection in mice. Stroke2003; 34:551–7.
9.
KawashimaSYamashitaTMiwaY. HMG-coa reductase inhibitor has protective effects against stroke events in stroke-prone spontaneously hypertensive rats. Stroke2003; 34:157–63.
10.
RikitakeYKimHHHuangZ. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke2005; 36:2251–7.
11.
SironiLCiminoMGuerriniU. Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage. Arterioscler Thromb Vasc Biol2003; 23:322–7.
12.
ChenJZhangZGLiY. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol2003; 53:743–51.
13.
ZhangLZhangZGDingGL. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat. Circulation2005; 29:3486–94.
14.
JonssonNAsplundK: Does pretreatment with statins improve clinical outcome after stroke? A pilot case-referent study. Stroke2001;32:1112–5.
15.
Marti-FabregasJGomisMArboixA. Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke2004;35:1117–21.
16.
GreiseneggerSMullnerMTentschertSLangWLalouschekW: Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events. J Neurol Sci2004; 221:5–10.
17.
ElkindMSVFlintACSciaccaRRSaccoRL: Use of lipid lowering agents prior to onset of ischemic stroke is associated with decreased mortality: the Northern Manhattan stroke study. Neurology2005; 65:253–8.
18.
MontanerJChaconPKrupinskiJ. Safety and efficacy of statins in the acute phase of ischemic stroke: the MISTICS trial. Stroke2004; 35:293.
